| abstract |
Compounds of formula XII where Ra, Rb, R2, R7 and X are as defined in the specification, or pharmaceutically acceptable salts thereof. The compounds described herein are prodrugs of compounds that exhibit inhibitory activity on neprilysin. Pharmaceutical compositions comprising compounds such as those described. Methods to use these compounds. Processes and intermediaries to prepare them. |